Free Trial
LON:4BB

4basebio (4BB) Share Price, News & Analysis

4basebio logo
GBX 1,100 -25.00 (-2.22%)
As of 04/25/2025 12:20 PM Eastern

About 4basebio Stock (LON:4BB)

Key Stats

Today's Range
1,100
1,122.50
50-Day Range
1,090.50
1,205
52-Week Range
1,020
1,820
Volume
693 shs
Average Volume
1,077 shs
Market Capitalization
£140.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 1,600
Consensus Rating
Buy

Company Overview

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.

Receive 4BB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter.

4BB Stock News Headlines

4basebio Plc - Director Dealing
Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…
See More Headlines

4BB Stock Analysis - Frequently Asked Questions

4basebio's stock was trading at GBX 1,210 at the start of the year. Since then, 4BB shares have decreased by 9.1% and is now trading at GBX 1,100.
View the best growth stocks for 2025 here
.

Shares of 4BB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that 4basebio investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:4BB
CIK
N/A
Fax
N/A
Employees
101
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 1,600
High Stock Price Target
GBX 1,600
Low Stock Price Target
GBX 1,600
Potential Upside/Downside
+45.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-9,840,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£311,000.00
Cash Flow
GBX 68.41 per share
Price / Cash Flow
16.08
Book Value
GBX (41) per share
Price / Book
-26.83

Miscellaneous

Free Float
N/A
Market Cap
£140.91 million
Optionable
Not Optionable
Beta
1.09
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (LON:4BB) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners